Find Clinical Trials
Phase I dose-escalation study of oral administration of S 78454 given with a fixed dose infusion of doxorubicin administered weekly 3 out of 4 weeks in patients with solid tumour
Servier Protocol Code:
CL1-78454-005
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2010-020954-33
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Solid tumors
- ABEXINOSTAT
- S078454
Other study id numbers
Other identification numbers the study may be known by.
- CL1-78454-005